Instructor in Obstetrics and Gynecology, Departments of General Surgery, and Obstetrics and Gynecology, University of Health Sciences Turkey, Istanbul, Turkey.
General Surgery and Surgical Oncology, Departments of General Surgery, and Obstetrics and Gynecology, University of Health Sciences Turkey, Istanbul, Turkey.
Libyan J Med. 2023 Dec;18(1):2258670. doi: 10.1080/19932820.2023.2258670. Epub 2023 Sep 20.
: Benign category of Bethesda classification is generally well known to carry a false-negative rate of 0-3%. The current study was designed to investigate the rate of false-negative cytology in patients who underwent thyroidectomy for presumably benign thyroid diseases. Predictive risk factors for false results and malignancy were evaluated along with cytology-histology discrepant cases.: Females who underwent thyroidectomy between May 2014 and December 2022 were included. Demographics, ultrasound (US) features, fine-needle aspiration (FNA) diagnosis, surgical indications and outcomes, final histology reports, risk factors, and malignancy rate were recorded. Cytology-histology discrepant cases were further evaluated for interpretation errors and risk factors. Statistical analyses were performed using Fisher's exact and Mann-Whitney U tests.: Of 581 women with a benign thyroid disease who underwent thyroidectomy, 91 was diagnosed as incidental carcinoma (15.6%) and most was T1a (4.9 ± 2.7 mm, 95.6%). Final histology reports revealed mostly papillary carcinoma (93.4%). Predictors of malignancy such as age, family history, previous radiation exposure, and iodine-deficient diet did not help in risk stratification ( > 0.05, for each). However, FNA taken during pregnancy was determined as a risk factor ( = 7, 7.6%, < 0.05) since it may cause a delay in diagnosis. Cytology-histology discrepant cases were seen to be mostly due to sampling errors (45%, < 0.05), followed by misinterpretations (37.3%, < 0.05). There was no reason for discrepancy in 17.5%, and this was linked to inherent nature of thyroid nodule with overlapping cytologic features. Best identifiable risk factor for misinterpretation was pregnancy as well ( = 5, 14.7%, < 0.05).: Risk of malignancy in a presumably benign thyroid disease should not be ignored. Radiology-cytology correlation by an experienced dedicated team may help in decreasing sampling errors. Physiologic changes caused by pregnancy may shade malignant transformation in thyrocytes, and it would be appropriate to be cautious about benign FNA taken during this period.
贝塞斯达分类中的良性类别通常被认为具有 0-3%的假阴性率。本研究旨在调查因疑似良性甲状腺疾病而行甲状腺切除术的患者中细胞学假阴性的发生率。评估了预测假结果和恶性肿瘤的风险因素,以及细胞学-组织学不一致的病例。
纳入 2014 年 5 月至 2022 年 12 月期间因良性甲状腺疾病行甲状腺切除术的女性患者。记录患者的人口统计学、超声(US)特征、细针穿刺(FNA)诊断、手术指征和结果、最终组织学报告、风险因素和恶性肿瘤发生率。对细胞学-组织学不一致的病例进行进一步评估,以确定解释错误和风险因素。使用 Fisher 精确检验和 Mann-Whitney U 检验进行统计学分析。
在 581 例因良性甲状腺疾病行甲状腺切除术的女性中,91 例诊断为偶然癌(15.6%),大多数为 T1a(4.9±2.7mm,95.6%)。最终组织学报告显示,大多数为乳头状癌(93.4%)。年龄、家族史、既往放射暴露和碘缺乏饮食等恶性肿瘤的预测因素并未有助于分层( > 0.05,各因素)。然而,妊娠期进行的 FNA 被确定为一个危险因素( = 7,7.6%, < 0.05),因为它可能导致诊断延迟。细胞学-组织学不一致的病例主要是由于取样误差(45%, < 0.05),其次是解释错误(37.3%, < 0.05)。17.5%的病例没有不一致的原因,这与具有重叠细胞学特征的甲状腺结节的固有性质有关。同样,妊娠也是导致解释错误的最佳可识别危险因素( = 5,14.7%, < 0.05)。
在疑似良性甲状腺疾病中,恶性肿瘤的风险不应被忽视。由经验丰富的专业团队进行放射学-细胞学相关性分析,可能有助于减少取样误差。妊娠引起的生理变化可能会使甲状腺细胞的恶性转化变得模糊,因此在这期间谨慎对待良性 FNA 是恰当的。